Alteration in Dissolution Characteristics of Gelatin-Containing Formulations: A Review of the Problem, Test Methods, and Solutions
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-04-02-2002
Volume 26
Issue 4
Eventual change in the dissolution characteristics of some dosage forms, which is ascribed to cross-linking of gelatin, continues to present challenges to drug manufacturers. The authors discuss the causes, mechanisms, and solutions to the problem.
Articles in this issue
Effect of Extragranular Microcrystalline Cellulose on Compaction, Surface Roughness, and In Vitro Dissolution of a Self-Nanoemulsified Solid Dosage Form of Ubiquinone
The Usefulness of 0.45 µm–Rated Filter Membranes
Outsourcing Outlook
Monitoring Blend Uniformity with Effusivity
Using Ion Mobility Spectrometry for Cleaning Verification in Pharmaceutical Manufacturing
Bush Budget Combats Bioterrorism, Promotes Drug Safety
Alteration in Dissolution Characteristics of Gelatin-Containing Formulations: A Review of the Problem, Test Methods, and Solutions
E-Procurement — Successfully Using and Managing Reverse Auctions
Liposomes: A Review
Recent Videos
Related Content
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024Podcast
In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
